1344 related articles for article (PubMed ID: 26281821)
21. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
23. High rates of quinolone resistance among urinary tract infections in the ED.
Khawcharoenporn T; Vasoo S; Ward E; Singh K
Am J Emerg Med; 2012 Jan; 30(1):68-74. PubMed ID: 21075586
[TBL] [Abstract][Full Text] [Related]
24. TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES.
Guneysel O; Suman E; Ozturk TC
Acta Clin Croat; 2016 Mar; 55(1):49-57. PubMed ID: 27333718
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
26. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
Perfetto EM; Keating K; Merchant S; Nichols BR
J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
[TBL] [Abstract][Full Text] [Related]
27. Addressing antibiotic resistance.
Gupta K
Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
[TBL] [Abstract][Full Text] [Related]
28. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Rock W; Colodner R; Chazan B; Elias M; Raz R
Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
[TBL] [Abstract][Full Text] [Related]
29. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
30. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of urinary tract infections and development of urinary-specific antibiogram for kidney transplant recipients.
Korayem GB; Zangeneh TT; Matthias KR
J Glob Antimicrob Resist; 2018 Mar; 12():119-123. PubMed ID: 28859935
[TBL] [Abstract][Full Text] [Related]
33. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
Wang SS; Ratliff PD; Judd WR
Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962
[TBL] [Abstract][Full Text] [Related]
34. Frequency and Antibiotic Resistance of Bacteria Implicated in Community Urinary Tract Infections in North Aveiro Between 2011 and 2014.
Costa T; Linhares I; Ferreira R; Neves J; Almeida A
Microb Drug Resist; 2018 May; 24(4):493-504. PubMed ID: 28922100
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
[TBL] [Abstract][Full Text] [Related]
36. Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection.
Boggan JC; Navar-Boggan AM; Jhaveri R
Pediatrics; 2012 Sep; 130(3):e615-22. PubMed ID: 22891227
[TBL] [Abstract][Full Text] [Related]
37. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
38. Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Davis WH; Magee MR; Monks SM; Geno KA; Crawford SB
Am J Emerg Med; 2022 Nov; 61():12-17. PubMed ID: 36027632
[TBL] [Abstract][Full Text] [Related]
39. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
Caterino JM; Weed SG; Espinola JA; Camargo CA
Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
[TBL] [Abstract][Full Text] [Related]
40. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
Gupta K; Hooton TM; Stamm WE
Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]